Customize
Quick Links

Accreditation/
Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

Physicians’ Education Resource®, is approved by the California Board of Registered Nursing, Provider #16669.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

14th Annual New York Lung Cancers Symposium

14th Annual New York Lung Cancers Symposium


14th Annual New York Lung Cancers Symposium

Saturday, November 9, 2019
New York Marriott Marquis
1535 Broadway
New York, NY 10036
212-398-1900

Overview:

At the 14th Annual New York Lung Cancers Symposium, you will experience a comprehensive overview of lung cancer diagnoses and multidisciplinary treatment. In recent years, we have redesigned the meeting to help you increase your knowledge and competence of lung cancer therapy, starting with the roles that surgery, radiology, pulmonology, and pathology play in ensuring the most accurate diagnosis of lung cancers. You will hear experts from the New York area discuss optimal approaches for early-stage and locally advanced disease as well as present the latest data on immunotherapy and targeted agents in metastatic lung cancers. Finally, you will get a preview of upcoming advances in local and systemic therapies for thoracic malignancies.

As in previous years, interactive case challenges will provide you with an opportunity to discuss the application of clinical data to real-world patient cases. For nurse practitioners and physician assistants, a special breakfast session will provide opportunities for learning and networking. We look forward to offering you this exciting meeting, centered on lung cancers, that will foster collaboration between you and other members of the multidisciplinary oncology team. This is a program you won’t want to miss!

What You Will Learn

  • Multidisciplinary approaches for patient diagnosis
  • Perioperative strategies for your patients with resectable disease
  • Immunotherapy and local modalities for stage III lung cancers
  • Targeting of immune checkpoints and oncogenic drivers in your patients with metastatic lung cancers
  • Application of clinical data in challenging case scenarios

Benefits of Attending

  • Networking with your peers
  • Asking questions of the faculty about your most challenging cases
  • Applying testing strategies to optimize tumor characterization and inform clinical decision making for the management of patients with lung cancers
  • Evaluating recent and emerging evidence concerning single-agent and combination immunotherapeutic approaches to manage lung cancers

Target Audience

This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, and pulmonologists involved in the treatment and management of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, investigators, and other healthcare professionals interested in the treatment of lung cancer may also participate.

Program Chairs

Mark G. Kris, MD
Attending Physician, Thoracic Oncology Service
William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY
 

Roman Perez-Soler, MD
Chairman, Department of Oncology
Montefiore Medical Center
Professor of Medicine and Molecular Pharmacology
Deputy Director, Cancer Center
Albert Einstein College of Medicine
Bronx, NY







Become a Member

Forgot Password?
Filter By